Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study

The Annals of Otology, Rhinology, and Laryngology
Elvira BuxóMarcial Garcia-Morillo

Abstract

In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin plus 5-FU for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). With the aim of improving fluoropyrimidine-related tolerance without decreasing its efficacy, the safety and efficacy of carboplatin plus the oral fluoropyrimidine tegafur and cetuximab were investigated. A retrospective analysis of 104 patients with recurrent or metastatic HNSCC was conducted. Patients were treated with carboplatin (area under the curve: 5 mg/mL/min) on day 1, oral tegafur (250 mg/m2 twice daily) for 21 consecutive days, and cetuximab (400 mg/m2 as an initial 2-hour intravenous infusion, then 250 mg/m2 as a 1-hour weekly infusion for 3 weeks) for ≤6 cycles. Patients who responded to the therapy then received weekly cetuximab maintenance therapy. Treatment was well tolerated with a high level of compliance (relative dose intensity: 96%, 88%, and 81% for carboplatin, tegafur, and cetuximab, respectively). Grade 3-4 adverse events (AEs) were observed in 38% of patients (skin reactions in 17% of patients, anemia 4%, and neutropenia 3%). Grade 1-2 AEs included skin re...Continue Reading

References

Feb 18, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeany M Rademaker-LakhaiJan H M Schellens
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C FontP Gascon
Mar 7, 2014·Seminars in Thrombosis and Hemostasis·Birgit Linnemann
Aug 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paolo CotogniMauro Pittiruti
Apr 24, 2016·Critical Reviews in Oncology/hematology·Gwo Yaw HoJermaine I G Coward

❮ Previous
Next ❯

Software Mentioned

EXTREME

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.